Graham Lidgard
Corporate Officer/Principal chez EXACT SCIENCES CORPORATION
Profil
Graham Peter Lidgard a fondé Matritech, Inc. Le Dr Lidgard est Chief Science Officer, SVP-Research & Development chez EXACT Sciences Corp. Au cours de sa carrière antérieure, il a occupé le poste de vice-président senior en charge de la recherche et du développement chez Ngen, Inc, vice-président en charge de la recherche et du développement chez Gen-Probe, Inc, vice-président en charge du développement des produits chez Matritech, Inc et vice-président en charge du développement des produits chez Ciba Corning Diagnostics Corp. Le Dr Lidgard a obtenu un diplôme de premier cycle et un doctorat de l'université de Manchester.
Postes actifs de Graham Lidgard
Sociétés | Poste | Début |
---|---|---|
EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 01/04/2021 |
Anciens postes connus de Graham Lidgard
Sociétés | Poste | Fin |
---|---|---|
NGEN INC | Chief Tech/Sci/R&D Officer | 10/08/2009 |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/06/2002 |
NANOGEN INC | Chief Tech/Sci/R&D Officer | - |
Ciba Corning Diagnostics Corp. | Corporate Officer/Principal | - |
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Founder | - |
Formation de Graham Lidgard
The University of Manchester | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
EXACT SCIENCES CORPORATION | Health Technology |
Entreprise privées | 5 |
---|---|
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Health Technology |
Ngen, Inc.
Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Ciba Corning Diagnostics Corp. | |
NANOGEN INC |